In the Commonwealth of Kentucky, mortality from lung cancer exceeds deaths from breast, colorectal, prostate and pancreatic cancer, combined. In an effort to improve survival of Kentuckians with lung cancer, the Kentucky General Assembly of 2000 established the Lung Cancer Research Fund. This 20-year initiative mandates the combined efforts of the University of Kentucky and the University of Louisville in lung cancer translation and clinical research, early detection and epidemiology initiatives, and the development of the Kentucky Clinical Trials Network. When mature these initiatives and programs will identify Kentucky as a leader in lung cancer epidemiology, diagnosis and treatment.
Priority initiatives stipulated in the enabling legislation include:
- Early detection and epidemiology of lung cancer
- A Kentucky Clinical Trials Network
- NCI designation as a cancer center
- Investigator-initiated lung cancer research